Author/Authors :
Califf، نويسنده , , Robert M and DeLong، نويسنده , , Elizabeth R and Ostbye، نويسنده , , Truls and Muhlbaier، نويسنده , , Lawrence K. and Chen، نويسنده , , Anita and LaPointe، نويسنده , , Nancy Allen and Hammill، نويسنده , , Bradley G and McCants Jr.، نويسنده , , Charles B and Kramer، نويسنده , , Judith M، نويسنده ,
Abstract :
Despite substantial evidence that antiplatelet therapy saves lives and reduces adverse events in patients with coronary artery disease (CAD), use of the most widely available and lowest cost antiplatelet agent, aspirin, continues to be disappointingly low
